STOCK TITAN

Celanese names Anne P. Noonan to two board committees

Celanese Corporation (CE) appointed director Anne P. Noonan to its Compensation and Management Development Committee and Nominating and Corporate Governance Committee on October 15, 2026, effective immediately.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K/A

Rhea-AI Filing Summary

Celanese Corporation (CE) appointed director Anne P. Noonan to its Compensation and Management Development Committee and Nominating and Corporate Governance Committee on October 15, 2026, effective immediately. Her committee appointments had not been determined when she joined the Board.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Committee appointment date October 15, 2026 Appointments effective immediately

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Which committees did CE director Anne P. Noonan join?

Anne P. Noonan joined Celanese's Compensation and Management Development Committee and Nominating and Corporate Governance Committee, effective October 15, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
0001306830false00013068302026-04-162026-04-160001306830us-gaap:CommonStockMember2026-04-162026-04-160001306830ce:EURSeniorUnsecuredNotesDue2027Member2026-04-162026-04-160001306830ce:EURSeniorUnsecuredNotesDue2028Member2026-04-162026-04-160001306830ce:EURSeniorUnsecuredNotesDue2029Member2026-04-162026-04-160001306830ce:EURSeniorUnsecuredNotesDue2031Member2026-04-162026-04-16

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
(Amendment No. 1)
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 16, 2026 (April 16, 2026)
CELANESE CORPORATION
(Exact name of registrant as specified in its charter)
Delaware001-3241098-0420726
(State or other jurisdiction
of incorporation)
(Commission File
Number)
(IRS Employer
Identification No.)
222 West Las Colinas Blvd. Suite 900N, Irving, TX 75039
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (972) 443-4000

N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of Each ClassTrading Symbol(s) Name of Each Exchange on Which Registered
Common Stock, par value $0.0001 per shareCEThe New York Stock Exchange
2.125% Senior Notes due 2027CE /27The New York Stock Exchange
0.625% Senior Notes due 2028CE /28The New York Stock Exchange
5.337% Senior Notes due 2029CE /29AThe New York Stock Exchange
5.000% Senior Notes due 2031CE /31The New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth company  ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐



Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
(d) Celanese Corporation (the “Company”) is filing this amendment to its Current Report on Form 8-K filed on April 20, 2026, which reported the election of Anne P. Noonan to the Board of Directors (the “Board”) of the Company. At the time of her election, the Board had not determined her appointments to any committees of the Board.
On October 15, 2026, the Board appointed Ms. Noonan to its Compensation and Management Development Committee and its Nominating and Corporate Governance Committee, effective immediately.




2


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CELANESE CORPORATION
 
By:/s/ ASHLEY B. DUFFIE
Name: Ashley B. Duffie
Title:Senior Vice President, General Counsel and Corporate Secretary 
Date:
October 20, 2026
3

Filing Exhibits & Attachments

4 documents

Keep reading